Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: A management strategy for urologic chronic pelvic pain syndromes

Prostate Cancer and Prostatic Diseases

Volumn 12, Issue 2, 2009, Pages 177-183

  Shoskes, D A ^a   Nickel, J C ^b   Rackley, R R ^a   Pontari, M A ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ANTIBIOTIC AGENT; PENTOSAN POLYSULFATE; QUERCETIN;

ABDOMINAL TENDERNESS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BLADDER FUNCTION; CHRONIC PROSTATITIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITIVE THERAPY; COPING BEHAVIOR; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; HUMAN; INTERSTITIAL CYSTITIS; LABORATORY TEST; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PHENOTYPE; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; TREATMENT PLANNING; TREATMENT RESPONSE; UROLOGIC CHRONIC PELVIC PAIN SYNDROME;

BIOLOGICAL MARKERS; CHRONIC DISEASE; CYSTITIS, INTERSTITIAL; HUMANS; MALE; PELVIC PAIN; PHENOTYPE; PROSTATITIS; SYNDROME;

EID: 67349110230     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2008.42     Document Type: Article

References (29)

1. Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236-237.
2. Taylor BC, Noorbaloochi S, McNaughton-Collins M, Saigal CS, Sohn MW, Pontari MA et al. Excessive antibiotic use in men with prostatitis. Am J Med 2008; 121: 444-449.
3. Shoskes DA, Katz E. Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 2005; 6: 296-299.
4. Fall M, Oberpenning F, Peeker R. Treatment of bladder pain syndrome/ interstitial cystitis 2008: Can we make evidence-based decisions? Eur Urol 2008.
5. Sairanen J, Tammela TL, Leppilahti M, Onali M, Forsell T, Ruutu M. Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: A prospective study with cyclosporine A and pentosan polysulfate sodium. Neurourol Urodyn 2007; 26: 267-270.
6. Dell JR, Parsons CL. Multimodal therapy for interstitial cystitis. J Reprod Med 2004; 49: 243-252.
7. Meeus M, Nijs J. Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 2007; 26: 465-473.
8. Tripp DA, Nickel JC, Wang Y, Litwin MS, McNaughton-Collins M, Landis JR et al. Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 2006; 7: 697-708.
9. Litwin MS, McNaughton-Collins M, Fowler Jr FJ, Nickel JC, Calhoun EA, Pontari MA et al. The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure. J Urol 1999; 162: 369-375.
10. O'Leary MP, Sant GR, Fowler FJJ, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49: 58-63.
11. Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Waxell T et al Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002; 60: 573-578.
12. Staab JP, Datto CJ, Weinrieb RM, Gariti P, Rynn M, Evans DL. Detection and diagnosis of psychiatric disorders in primary medical care settings. Med Clin North Am 2001; 85: 579-596.
13. Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O'Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med 1997; 20: 589-605.
14. Nickel JC, Shoskes D, Wang Y, Alexander RB, Fowler JEJ, Zeitlin S et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol 2006; 176: 119-124.
15. Potts JM, Ward AM, Rackley RR. Association of chronic urinary symptoms in women and Ureaplasma urealyticum. Urology 2000; 55: 486-489.
16. Rosenberg MT, Page S, Hazzard MA. Prevalence of interstitial cystitis in a primary care setting. Urology 2007; 69: 48-52.
17. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54: 960-963.
18. Shoskes DA. Phytotherapy and other alternative forms of care for the patient with prostatitis. Curr Urol Rep 2002; 3: 330-334.
19. Katske F, Shoskes DA, Sender M, Poliakin R, Gagliano K, Rajfer J. Treatment of interstitial cystitis with a quercetin supplement. Tech Urol 2001; 7: 44-46.
20. Kelly JD, Young MR, Johnston SR, Keane PF. Clinical response to an oral prostaglandin analogue in patients with interstitial cystitis. Eur Urol 1998; 34: 53-56.
21. Gheyi SK, Robertson A, Atkinson PM. Severe interstitial cystitis caused by tiaprofenic acid. J R Soc Med 1999; 92: 17.
22. Nickel JC, Xiang J. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 2008; 179: 1391-1395.
23. Warren JW, Horne LM, Hebel JR, Marvel RP, Keay SK, Chai TC. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J Urol 2000; 163: 1685-1688.
24. Pontari MA, McNaughton-Collins M, O'leary MP, Calhoun EA, Jang T, Kusek JW et al. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005; 96: 559-565.
25. Lee SW, Liong ML, Yuen KH, Leong WS, Chee C, Cheah PY et al. Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain. Am J Med 2008; 121: 79.e1-79.e7.
26. Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol 2008; 179: 556-560.
27. Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol 2005; 174: 155-160.
28. Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 2008; 179: 1031-1034.
29. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int 2004; 93: 777-779.